背景:母婴结局存在斯塔克差异,需要提供及时准确的健康信息。
目的:在本试验研究中,我们评估了健康聊天机器人对有色新妈妈的可行性和可接受性。
方法:Rosie,一个问答聊天机器人,是作为移动应用程序开发的,可以回答有关怀孕的问题,育儿,和儿童发展。从2023年1月9日至2023年2月9日,参与者使用社交媒体帖子并通过与社区组织的接触被招募。纳入标准包括年龄≥14岁,作为一个有色人种的女人,并且目前正在怀孕或在过去6个月内分娩。参与者被随机分配到Rosie治疗组(15/29,52%接受Rosie应用程序)或对照组(14/29,48%每月接受一本儿童读物),为期3个月。分配到治疗组的人可以向Rosie提问,并从Rosie的知识库中获得即时响应。一旦发现可能的健康紧急情况,Rosie发送紧急资源和相关热线信息。此外,一名研究人员,他是一名临床社会工作者,在24小时内联系参与者进行跟进。完成了干预前和干预后测试,以定性和定量评估Rosie并描述关键健康结果的变化,包括产后抑郁症和急诊室就诊的频率。这些测量用于告知临床试验的样本量计算。
结果:在接受筛查并符合条件的41个人中,31(76%)和29(71%)保留在研究中。超过87%(13/15)的Rosie治疗组成员报告在3个月的研究期间每天(5/15,33%)或每周(8/15,53%)使用Rosie。大多数用户报告说Rosie易于使用(14/15,93%),并提供快速响应(13/15,87%)。确定的其余问题包括应用程序崩溃(8/15,53%),用户对Rosie的一些答案不满意(12/15,80%)。Rosie治疗组和对照组的母亲从测试前到测试后均经历了抑郁评分的下降,但下降仅在治疗组母亲中具有统计学意义(P=.008)。此外,与对照组成员(3/13,23%)相比,治疗组婴儿接受急诊室就诊的比例较低(1/11,9%).尽管如此,组间差异无统计学意义,P<0.05。
结论:发现Rosie是可以接受的,可行,和适当的干预种族和种族少数孕妇和婴儿的母亲由于聊天机器人的能力,以提供个性化的,灵活的工具,以增加高质量健康信息的及时性和可及性,以个人在母亲和孩子的健康风险升高期间。
背景:ClinicalTrials.govNCT06053515;https://clinicaltrials.gov/study/NCT06053515。
BACKGROUND: Stark disparities exist in maternal and child outcomes and there is a need to provide timely and accurate health information.
OBJECTIVE: In this pilot study, we assessed the feasibility and acceptability of a health chatbot for new mothers of color.
METHODS: Rosie, a question-and-answer chatbot, was developed as a mobile app and is available to answer questions about pregnancy, parenting, and child development. From January 9, 2023, to February 9, 2023, participants were recruited using social media posts and through engagement with community organizations. Inclusion criteria included being aged ≥14 years, being a woman of color, and either being currently pregnant or having given birth within the past 6 months. Participants were randomly assigned to the Rosie treatment group (15/29, 52% received the Rosie app) or control group (14/29, 48% received a children\'s book each month) for 3 months. Those assigned to the treatment group could ask Rosie questions and receive an immediate response generated from Rosie\'s knowledgebase. Upon detection of a possible health emergency, Rosie sends emergency resources and relevant hotline information. In addition, a study staff member, who is a clinical social worker, reaches out to the participant within 24 hours to follow up. Preintervention and postintervention tests were completed to qualitatively and quantitatively evaluate Rosie and describe changes across key health outcomes, including postpartum depression and the frequency of emergency room visits. These measurements were used to inform the clinical trial\'s sample size calculations.
RESULTS: Of 41 individuals who were screened and eligible, 31 (76%) enrolled and 29 (71%) were retained in the study. More than 87% (13/15) of Rosie treatment group members reported using Rosie daily (5/15, 33%) or weekly (8/15, 53%) across the 3-month study period. Most users reported that Rosie was easy to use (14/15, 93%) and provided responses quickly (13/15, 87%). The remaining issues identified included crashing of the app (8/15, 53%), and users were not satisfied with some of Rosie\'s answers (12/15, 80%). Mothers in both the Rosie treatment group and control group experienced a decline in depression scores from pretest to posttest periods, but the decline was statistically significant only among treatment group mothers (P=.008). In addition, a low proportion of treatment group infants had emergency room visits (1/11, 9%) compared with control group members (3/13, 23%). Nonetheless, no between-group differences reached statistical significance at P<.05.
CONCLUSIONS: Rosie was found to be an acceptable, feasible, and appropriate intervention for ethnic and racial minority pregnant women and mothers of infants owing to the chatbot\'s ability to provide a personalized, flexible tool to increase the timeliness and accessibility of high-quality health information to individuals during a period of elevated health risks for the mother and child.
BACKGROUND: ClinicalTrials.gov NCT06053515; https://clinicaltrials.gov/study/NCT06053515.